Micropaque Suspension

Barium sulfate, the active ingredient in Micropaque Suspension, is a contrast agent presented as a suspension for oral and rectal use. It provides radiopaque coating for gastrointestinal imaging in patients undergoing diagnostic procedures.

GNH USA supplies Micropaque Suspension as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Micropaque Suspension is a barium‑based contrast agent used in gastrointestinal radiographic examinations.

Upper gastrointestinal tract imaging: enables visualization of the esophagus, stomach and duodenum during a barium swallow. Lower gastrointestinal tract imaging: provides coating of the colon and rectum for a barium enema. Small bowel follow‑through: outlines the small intestine for detailed assessment.

Micropaque Suspension may cause a range of adverse reactions.

Common Side Effects: - Nausea: mild transient feeling of sickness. - Abdominal cramping: temporary discomfort in the abdomen. - Constipation: difficulty passing stool after the procedure. - Metallic taste: brief alteration in taste perception.

Serious or Rare Side Effects: - Barium impaction: blockage of the gastrointestinal tract requiring medical intervention. - Allergic reaction: rash, itching or swelling indicating hypersensitivity. - Aspiration: inhalation of barium into the lungs leading to respiratory complications.

Before using Micropaque Suspension, consider the following safety measures.

Patient assessment: evaluate for existing bowel obstruction or perforation. Recent GI surgery: avoid if the patient has had recent gastrointestinal procedures. Allergy history: screen for known hypersensitivity to barium sulfate or related compounds. Hydration: ensure adequate fluid intake after administration to facilitate clearance. Pregnancy: use only when essential, after risk‑benefit assessment. Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Micropaque Suspension can interact with other agents that affect gastrointestinal imaging or motility.

Major Interactions (Avoid): - Other oral contrast agents: may obscure imaging results. - Antacids containing aluminum or magnesium: can alter barium coating. - High‑dose iron supplements: may bind barium and affect radiopacity.

Moderate Interactions (Monitor Closely): - Prokinetic drugs (e.g., metoclopramide): may change barium transit time. - Opioid analgesics: can slow gastrointestinal motility, affecting study quality.